[18F]SPA-RQ
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]SPA-RQ, covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ [Phase 1]